University of Alberta
Gamper Lab
  • Home
  • Research
  • about the PI
  • Publications and Labmembers
    • Lab Members
  • Opportunities and more...
    • Opportunities
    • Radiation Biology
    • Contact
    • more...
Overview

Higher eukaryotes have evolved a complex DNA damage response that involves DNA repair, cell cycle control and apoptosis. Aberration in each of these cellular processes can contribute to cancer development. At the same time fast proliferating cells such as cancer cells are particularly vulnerable to unrepaired DNA damage. This provides the basis for radiotherapy and most chemotherapies. Elucidating the mechanisms governing DNA repair and the DNA damage response therefore can help both cancer prevention and therapy. The focus of our experimental radiation oncology lab, established in 2015 at the University of Alberta, is to translate our knowledge of the DNA damage response to improve radiation therapy. Current research interests in the lab include in vitro and in vivo studies of: 1) the DNA damage signalling mechanisms and the therapeutic potential of targeting them; 2) mouse models to study radiation injury to the large intestine to mitigate pelvic radiation disease; 3) combination treatments to improve anti-tumour immune responses; 4) development of non-invasive imaging tools to assess tumour response to ionizing radiation; 5) development of new therapies for difficult to treat cancers. My long-term goal is to find treatments that a) increase tumour control (such as radiosensitizers for radiation therapy), b) reduce metastasis, and/or c) increase the quality of life of cancer patients (e.g., by reducing side effects).
            Our experimental radiation oncology lab combines the expertise in various disciplines to enable the knowledge transfer from molecular findings to preclinical studies in animals and ultimately to the clinic.
For recent events in the Gamper lab, click here!
Powered by Create your own unique website with customizable templates.